YU46597B - Postupak za proizvodnju hibridni interferoni humanih leukocita - Google Patents
Postupak za proizvodnju hibridni interferoni humanih leukocitaInfo
- Publication number
- YU46597B YU46597B YU265681A YU265681A YU46597B YU 46597 B YU46597 B YU 46597B YU 265681 A YU265681 A YU 265681A YU 265681 A YU265681 A YU 265681A YU 46597 B YU46597 B YU 46597B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- polypeptide
- microorganism
- fragment
- production
- human leukocytes
- Prior art date
Links
- 102000014150 Interferons Human genes 0.000 title abstract 4
- 108010050904 Interferons Proteins 0.000 title abstract 4
- 229940047124 interferons Drugs 0.000 title abstract 3
- 210000000265 leukocyte Anatomy 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 239000012634 fragment Substances 0.000 abstract 3
- 244000005700 microbiome Species 0.000 abstract 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 1
- 102000053602 DNA Human genes 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 229940079322 interferon Drugs 0.000 abstract 1
- 230000002934 lysing effect Effects 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
POSTUPAK ZA PROIZVODNJU HIBRIDNI INTERFERONI HUMANIH LEUKOCITA, s tim što aminokiselinska sekvenca pomenutog polipeptida obuhvata, u nizu, zasebne subsekvence koje po identitetu i broju aminokiselina odgovaraju subsekvencama različitih, prirodnih leukocitnih interferona i što se sekvenca aminokiselina pomenutog polipeptida razlikuje u ukupnom sastavu od sekvence aminokiselina prirodnih leukocitnih interferona, nazn ačen time, što obuhvata formiranje jednog fragmenta hibridne dvolančane DNK koji sadrži lanac koji šifruje za pomenuti polipeptid unutar replikabilnog plazmidnog eksprimirajućeg vektora, transformaciju nekog mikroorganizma sa tim fragmentom, gajenje ovog mikroorganizma i omogućavanje ekspresije polipeptida koji je u obliku šifre sadržan u tom fragmentu, liziranje rezultirajućeg mikroorganizma i izdvajanje pomenutog polipeptida iz njega. Prijava sadrži još 6 nezavisnih i 17 zavisnih zahteva.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20557980A | 1980-11-10 | 1980-11-10 | |
US06/237,388 US4414150A (en) | 1980-11-10 | 1981-02-23 | Hybrid human leukocyte interferons |
US06/305,657 US4456748A (en) | 1981-02-23 | 1981-09-25 | Hybrid human leukocyte interferons |
Publications (2)
Publication Number | Publication Date |
---|---|
YU265681A YU265681A (en) | 1984-08-31 |
YU46597B true YU46597B (sh) | 1994-01-20 |
Family
ID=27394813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU265681A YU46597B (sh) | 1980-11-10 | 1981-11-10 | Postupak za proizvodnju hibridni interferoni humanih leukocita |
Country Status (34)
Country | Link |
---|---|
EP (1) | EP0051873B1 (sh) |
JP (1) | JP2642291B2 (sh) |
KR (1) | KR920007439B1 (sh) |
AT (1) | ATE46718T1 (sh) |
AU (1) | AU555293B2 (sh) |
BR (1) | BR8107293A (sh) |
CA (2) | CA1212915A (sh) |
CH (2) | CH663032A5 (sh) |
DE (2) | DE3144469A1 (sh) |
DK (1) | DK173590B1 (sh) |
DO (1) | DOP1981004064A (sh) |
DZ (1) | DZ350A1 (sh) |
ES (2) | ES506955A0 (sh) |
FI (1) | FI79550C (sh) |
FR (1) | FR2493867B1 (sh) |
GB (1) | GB2090258B (sh) |
GR (1) | GR81947B (sh) |
HK (1) | HK51685A (sh) |
IE (1) | IE51850B1 (sh) |
IL (1) | IL64243A (sh) |
IT (1) | IT1169276B (sh) |
KE (1) | KE3536A (sh) |
LU (1) | LU83745A1 (sh) |
MC (1) | MC1424A1 (sh) |
MY (2) | MY8700710A (sh) |
NL (1) | NL189092C (sh) |
NO (1) | NO165201C (sh) |
NZ (1) | NZ198906A (sh) |
PH (1) | PH18565A (sh) |
PL (1) | PL233748A1 (sh) |
PT (1) | PT73955B (sh) |
SE (1) | SE460539B (sh) |
YU (1) | YU46597B (sh) |
ZW (1) | ZW26981A1 (sh) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH651308A5 (de) * | 1980-07-01 | 1985-09-13 | Hoffmann La Roche | Interferone und deren herstellung. |
JPS58501543A (ja) * | 1981-08-14 | 1983-09-16 | エイ/エス アルフレツド ベンツオン | ヒトインタ−フエロン蛋白とヒトインタ−フエロン蛋白に対する抗体に関する改良 |
EP0072541A3 (en) * | 1981-08-14 | 1984-04-18 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them |
GB2108510B (en) * | 1981-10-03 | 1984-12-12 | Ciba Geigy Ag | Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof |
IT1167610B (it) * | 1982-01-19 | 1987-05-13 | Cetus Corp | Interfreron ibrido multiclasse, composizione farmaceutica che lo contiene e procedimento di produzione |
DE3220116A1 (de) * | 1982-05-28 | 1983-12-01 | Dr. Karl Thomae Gmbh, 7950 Biberach | Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung |
IE56509B1 (en) * | 1982-11-04 | 1991-08-28 | Univ California | Methods for oncogenic detection |
WO1984003300A1 (en) * | 1983-02-24 | 1984-08-30 | Inst Organicheskogo Sinteza Ak | Leukocytic human interferon n and method to obtain it in bacterial cells |
GB8315980D0 (en) * | 1983-06-10 | 1983-07-13 | Biogen Nv | Producing hybrid dna sequences |
GB8317880D0 (en) * | 1983-07-01 | 1983-08-03 | Searle & Co | Structure and synthesis of interferons |
EP0146903A3 (en) * | 1983-12-19 | 1987-07-22 | Schering Corporation | Production of a vector encoding a novel hybrid interferon species |
US4892743A (en) * | 1983-12-21 | 1990-01-09 | Schering Corporation | Novel hybrid interferon species |
DE3409966A1 (de) * | 1984-03-19 | 1985-09-26 | Hoechst Ag, 6230 Frankfurt | Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens |
JPS6156199A (ja) * | 1984-08-27 | 1986-03-20 | Shionogi & Co Ltd | 新規ヒトインタ−フエロンα類 |
EP0173935A1 (en) * | 1984-08-31 | 1986-03-12 | University Patents, Inc. | Hybrid lymphoblastoid-leukocyte human interferons |
DE3434345A1 (de) * | 1984-09-19 | 1986-03-27 | Hoechst Ag, 6230 Frankfurt | Verwendung von (alpha)-interferonen zur bekaempfung von durchfaellen |
DE3685044D1 (de) * | 1985-02-01 | 1992-06-04 | Ici Plc | Analoge interferon-polypeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. |
DE3685996T2 (de) * | 1985-06-11 | 1993-01-14 | Ciba Geigy Ag | Hybrid-interferone. |
EP0240550A4 (en) * | 1985-09-26 | 1989-09-19 | Genetics Inst | LUNG SURFACE ACTIVE PROTEINS. |
US4806347A (en) * | 1985-12-11 | 1989-02-21 | Schering Corporation | Interferon combinations |
EP0490233A1 (de) * | 1986-03-10 | 1992-06-17 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Monoclonale Antikörper gegen BgIII-Hybridinterferone, deren Verwendung und Verfahren zu ihrer Herstellung |
DE3607835A1 (de) * | 1986-03-10 | 1987-09-24 | Boehringer Ingelheim Int | Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung |
US4851220A (en) * | 1986-11-26 | 1989-07-25 | Schering Corporation | Stable oleaginous gel |
US4853218A (en) * | 1987-02-24 | 1989-08-01 | Schering Corporation | Zinc-protamine-alpha interferon complex |
EP0331635A3 (en) * | 1988-02-29 | 1990-02-28 | The Board of Regents of the University of Texas System | Preparations for treating bladder cancer |
US5372808A (en) † | 1990-10-17 | 1994-12-13 | Amgen Inc. | Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect |
GB2273931A (en) * | 1992-09-28 | 1994-07-06 | Unilever Plc | Mutant polypeptides |
EP0830368A1 (en) | 1995-06-07 | 1998-03-25 | Genta Incorporated | Novel carbamate-based cationic lipids |
TW442492B (en) * | 1995-07-26 | 2001-06-23 | Novartis Ag | Process for the enrichment of interferon |
FR2823220B1 (fr) | 2001-04-04 | 2003-12-12 | Genodyssee | Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo) |
US7314613B2 (en) | 2002-11-18 | 2008-01-01 | Maxygen, Inc. | Interferon-alpha polypeptides and conjugates |
WO2005113592A2 (en) | 2004-05-19 | 2005-12-01 | Maxygen, Inc. | Interferon-alpha polypeptides and conjugates |
BRPI0609809A2 (pt) | 2005-05-18 | 2011-10-11 | Maxygen Inc | polipeptìdeo isolado ou recombinante, conjugado, composição, polinucleotìdeo isolado ou recombinante, célula hospedeira, vetor, métodos para preparar o polipeptìdeo, para preparar um conjugado, para inibir replicação de um vìrus em células infectadas com o vìrus para reduzir o numero de cópias de um vìrus em células infectadas com o vìrus, para reduzir o nìvel de rna de hcv no soro de um paciente infectado com hcv, para reduzir o nìvel de dna de hbv em soro de um paciente infectado com hbv e para reduzir o nìvel de rna de hiv em soro de um paciente infectado com hiv, e, uso do polipeptìdeo ou do conjugado |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3165463D1 (en) * | 1980-01-08 | 1984-09-20 | Biogen Nv | Dna sequences, recombinant dna molecules and processes for producing human interferon-alpha like polypeptides |
-
1981
- 1981-11-07 ES ES506955A patent/ES506955A0/es active Granted
- 1981-11-09 DZ DZ816369A patent/DZ350A1/fr active
- 1981-11-09 CH CH5574/85A patent/CH663032A5/de not_active IP Right Cessation
- 1981-11-09 EP EP81109579A patent/EP0051873B1/en not_active Expired
- 1981-11-09 IL IL64243A patent/IL64243A/xx not_active IP Right Cessation
- 1981-11-09 PT PT73955A patent/PT73955B/pt unknown
- 1981-11-09 NO NO813785A patent/NO165201C/no not_active IP Right Cessation
- 1981-11-09 IE IE2622/81A patent/IE51850B1/en not_active IP Right Cessation
- 1981-11-09 MC MC811558A patent/MC1424A1/xx unknown
- 1981-11-09 GB GB8133762A patent/GB2090258B/en not_active Expired
- 1981-11-09 PL PL23374881A patent/PL233748A1/xx unknown
- 1981-11-09 NZ NZ198906A patent/NZ198906A/en unknown
- 1981-11-09 CA CA000389688A patent/CA1212915A/en not_active Expired
- 1981-11-09 DE DE19813144469 patent/DE3144469A1/de not_active Ceased
- 1981-11-09 CH CH7174/81A patent/CH660743A5/de not_active IP Right Cessation
- 1981-11-09 FR FR8120943A patent/FR2493867B1/fr not_active Expired
- 1981-11-09 AU AU77304/81A patent/AU555293B2/en not_active Expired
- 1981-11-09 SE SE8106641A patent/SE460539B/sv not_active Application Discontinuation
- 1981-11-09 AT AT81109579T patent/ATE46718T1/de not_active IP Right Cessation
- 1981-11-09 DK DK198104946A patent/DK173590B1/da active
- 1981-11-09 PH PH26462A patent/PH18565A/en unknown
- 1981-11-09 DE DE8181109579T patent/DE3177106D1/de not_active Expired
- 1981-11-09 GR GR66464A patent/GR81947B/el unknown
- 1981-11-10 KR KR1019810004343A patent/KR920007439B1/ko active
- 1981-11-10 BR BR8107293A patent/BR8107293A/pt unknown
- 1981-11-10 DO DO1981004064A patent/DOP1981004064A/es unknown
- 1981-11-10 IT IT24967/81A patent/IT1169276B/it active
- 1981-11-10 ZW ZW269/81A patent/ZW26981A1/xx unknown
- 1981-11-10 LU LU83745A patent/LU83745A1/de unknown
- 1981-11-10 FI FI813539A patent/FI79550C/fi not_active IP Right Cessation
- 1981-11-10 NL NLAANVRAGE8105078,A patent/NL189092C/xx not_active IP Right Cessation
- 1981-11-10 YU YU265681A patent/YU46597B/sh unknown
-
1982
- 1982-05-19 ES ES512354A patent/ES8304200A1/es not_active Expired
-
1984
- 1984-12-18 CA CA000470467A patent/CA1277616C/en not_active Expired - Lifetime
-
1985
- 1985-05-21 KE KE3536A patent/KE3536A/xx unknown
- 1985-07-04 HK HK516/85A patent/HK51685A/xx not_active IP Right Cessation
-
1987
- 1987-12-30 MY MY710/87A patent/MY8700710A/xx unknown
-
1988
- 1988-12-30 MY MY66/88A patent/MY8800066A/xx unknown
-
1992
- 1992-12-28 JP JP4349148A patent/JP2642291B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU46597B (sh) | Postupak za proizvodnju hibridni interferoni humanih leukocita | |
YU47700B (sh) | Interferoni i postupak za njihovo dobivanje | |
EP0048970A3 (en) | Polypeptides, process for their microbial production, intermediates therefor and compositions containing them | |
DE69230993D1 (de) | Rekombinante viren vektoren zur expression in muskelzellen | |
ES8308534A1 (es) | Un metodo de producir un polipeptido que exhibe actividad inmunologica o biologica del interferon de leucocitos humanos. | |
IT8119760A0 (it) | Polipeptide prodotto microbiologicamente con la sequenza di aminoacidi dell'interferone umano, dna e plasmidi che codificano per questa sequenza, microorganismi che contengono queste informazioni genetiche e processo per la loro preparazione. | |
DE69333346D1 (de) | Neuartiges p- selectin ligandenprotein | |
ATE48643T1 (de) | Verfahren zur herstellung von glucagon oder dessen derivaten in einem transformierten hefestamm. | |
SE8703539D0 (sv) | Artificiell gen och proteinprodukt | |
MX9203645A (es) | Nuevos interferones de humano y proceso biotecnologico para su produccion. | |
EP0139878A3 (en) | Production of immune interferon and its mrna | |
BR8108074A (pt) | Sequencia de dna,plasmidio recombinante,ligadores de dna,cultura bacterial e processo para produzir taumatina | |
EP0072541A3 (en) | Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them | |
ATE91717T1 (de) | Verfahren zur herstellung von proteinen in loeslicher form. | |
EP0422217A4 (en) | Human recombinant placental ribonuclease inhibitor and method of production |